subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:78162481

object_name: Stage IV Prostate Cancer AJCC v8

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:78162481

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:78162481

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:78162481

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:78162481

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:78162481

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:78162481

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:78162481

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:78162481

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:78162481

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:78162481

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:78162481

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:78162481

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:78162481

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Unresectable Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:78162481

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:78162481

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:78162481

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:78162481

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:78162481

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:78162481

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:78162481

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:78162481

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:78162481

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:78162481

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:78162481

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78162481

object_name: anemia


subject: PUBCHEM.COMPOUND:78162481

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:78162481

object_name: myelofibrosis


subject: CHEBI:149504

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:149504

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:149504

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:149504

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:149504

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:149504

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:149504

object_name: Blast Phase


subject: CHEBI:149504

object_name: castration-resistant prostate carcinoma


subject: CHEBI:149504

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:149504


subject: CHEBI:149504

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:149504

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:149504

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:149504

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:149504

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:149504

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:149504

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:149504

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:149504

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:149504

object_name: Plasma cell myeloma recurrent


subject: CHEBI:149504

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:149504

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:149504

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:149504

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:149504

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:149504

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:149504

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:149504

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:149504

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:149504

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:149504

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:149504

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:149504

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:149504

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:149504

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:149504

object_name: refractory hematologic cancer


subject: CHEBI:149504

object_name: Refractory acute myeloid leukemia


subject: CHEBI:149504

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:149504

object_name: Plasma cell myeloma refractory


subject: CHEBI:149504

object_name: Metastatic Breast Carcinoma


subject: CHEBI:149504

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:149504

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:149504

object_name: anemia


subject: CHEBI:149504

object_name: Anemia, CTCAE


subject: CHEBI:149504

object_name: myelofibrosis


subject: CHEBI:6541

subject_name: Losartan

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:6541

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:6541

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:6541

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:6541

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:6541

object_name: Blast Phase


subject: CHEBI:6541

object_name: castration-resistant prostate carcinoma


subject: CHEBI:6541

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:6541


subject: CHEBI:6541

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:6541

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:6541

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:6541

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:6541

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:6541

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:6541

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:6541

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:6541

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:6541

object_name: Plasma cell myeloma recurrent


subject: CHEBI:6541

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:6541

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:6541

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:6541

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:6541

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:6541

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:6541

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:6541

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:6541

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:6541

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:6541

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:6541

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:6541

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:6541

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:6541

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:6541

object_name: refractory hematologic cancer


subject: CHEBI:6541

object_name: Refractory acute myeloid leukemia


subject: CHEBI:6541

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:6541

object_name: Plasma cell myeloma refractory


subject: CHEBI:6541

object_name: Metastatic Breast Carcinoma


subject: CHEBI:6541

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:6541

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:6541

object_name: anemia


subject: CHEBI:6541

object_name: Anemia, CTCAE


subject: CHEBI:6541

object_name: myelofibrosis


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Stage IV Prostate Cancer AJCC v8


subject: MESH:C520255

object_name: myelodysplastic syndrome with ring sideroblasts


subject: MESH:C520255

object_name: leukemia, myeloid, accelerated-phase


subject: MESH:C520255

object_name: Leukemia, Myeloid, Chronic-Phase


subject: MESH:C520255

object_name: Blast Phase


subject: MESH:C520255

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: MESH:C520255


subject: MESH:C520255

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: MESH:C520255

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: MESH:C520255

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: MESH:C520255

object_name: hematopoietic and lymphoid system neoplasm


subject: MESH:C520255

object_name: Recurrent Chronic Lymphoid Leukemia


subject: MESH:C520255

object_name: Recurrent Myeloproliferative Neoplasm


subject: MESH:C520255

object_name: Recurrent Hematologic Malignancy


subject: MESH:C520255

object_name: Acute lymphoblastic leukemia recurrent


subject: MESH:C520255

object_name: Plasma cell myeloma recurrent


subject: MESH:C520255

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: MESH:C520255

object_name: Recurrent Hodgkin Lymphoma


subject: MESH:C520255

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: MESH:C520255

object_name: Recurrent Adult Hodgkin Lymphoma


subject: MESH:C520255

object_name: Recurrent Myelodysplastic Syndrome


subject: MESH:C520255

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: MESH:C520255

object_name: Stage III Non-Hodgkin Lymphoma


subject: MESH:C520255

object_name: Refractory Acute Lymphoblastic Leukemia


subject: MESH:C520255

object_name: Chronic lymphocytic leukaemia refractory


subject: MESH:C520255

object_name: Recurrent Acute Myeloid Leukemia


subject: MESH:C520255

object_name: Refractory Primary Myelofibrosis


subject: MESH:C520255

object_name: Stage IV Non-Hodgkin Lymphoma


subject: MESH:C520255

object_name: Refractory Malignant Solid Neoplasm


subject: MESH:C520255

object_name: Stage III Hodgkin Lymphoma


subject: MESH:C520255

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: MESH:C520255

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: MESH:C520255

object_name: Recurrent Non-Hodgkin Lymphoma


subject: MESH:C520255

object_name: Refractory Myelodysplastic Syndrome


subject: MESH:C520255

object_name: Stage IV Hodgkin Lymphoma


subject: MESH:C520255

object_name: refractory hematologic cancer


subject: MESH:C520255

object_name: Refractory acute myeloid leukemia


subject: MESH:C520255

object_name: Plasma cell myeloma refractory


subject: MESH:C520255

object_name: Refractory Hodgkin Lymphoma


subject: MESH:C520255

object_name: Refractory Childhood Hodgkin Lymphoma


subject: MESH:C520255

object_name: anemia


subject: MESH:C520255

object_name: Anemia, CTCAE


subject: MESH:C520255

object_name: myelofibrosis


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:45863

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:45863

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:45863

object_name: Blast Phase


subject: CHEBI:45863

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:45863

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:45863

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:45863

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:45863

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:45863

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:45863

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:45863

object_name: Plasma cell myeloma recurrent


subject: CHEBI:45863

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:45863

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:45863

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:45863

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:45863

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:45863

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:45863

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:45863

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:45863

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:45863

object_name: refractory hematologic cancer


subject: CHEBI:45863

object_name: Refractory acute myeloid leukemia


subject: CHEBI:45863

object_name: Plasma cell myeloma refractory

tested_intervention: yes


subject: CHEBI:45863

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:45863

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:45863

object_name: myelofibrosis


subject: CHEBI:61397

subject_name: Neratinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:61397

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:61397

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:61397

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:61397

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:61397

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:61397

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:61397

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:61397

object_name: Blast Phase


subject: CHEBI:61397

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:61397


subject: CHEBI:61397

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:61397

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:61397

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:61397

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:61397

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:61397

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:61397

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:61397

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:61397

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:61397

object_name: Plasma cell myeloma recurrent


subject: CHEBI:61397

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:61397

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:61397

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:61397

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:61397

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:61397

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:61397

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:61397

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:61397

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:61397

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:61397

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:61397

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:61397

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:61397

object_name: refractory hematologic cancer


subject: CHEBI:61397

object_name: Refractory acute myeloid leukemia


subject: CHEBI:61397

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:61397

object_name: Plasma cell myeloma refractory


subject: CHEBI:61397

object_name: Metastatic Breast Carcinoma


subject: CHEBI:61397

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:61397

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:61397

object_name: anemia


subject: CHEBI:61397

object_name: Anemia, CTCAE


subject: CHEBI:61397

object_name: myelofibrosis


subject: CHEBI:231614

subject_name: Nivolumab

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:231614

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:231614

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:231614

object_name: Blast Phase


subject: CHEBI:231614


subject: CHEBI:231614

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:231614

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:231614

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:231614

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:231614

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:231614

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:231614

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:231614

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:231614

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:231614

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:231614

object_name: refractory hematologic cancer


subject: CHEBI:231614

object_name: Metastatic Breast Carcinoma


subject: CHEBI:231614

object_name: anemia


subject: CHEBI:231614

object_name: Anemia, CTCAE


subject: CHEBI:231614

object_name: myelofibrosis


subject: UMLS:C2346820

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UMLS:C2346820

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C2346820

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C2346820

object_name: Blast Phase


subject: UMLS:C2346820


subject: UMLS:C2346820

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UMLS:C2346820

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C2346820

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UMLS:C2346820

object_name: Recurrent Myeloproliferative Neoplasm


subject: UMLS:C2346820

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UMLS:C2346820

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UMLS:C2346820

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UMLS:C2346820

object_name: Stage III Non-Hodgkin Lymphoma


subject: UMLS:C2346820

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C2346820

object_name: Refractory Primary Myelofibrosis


subject: UMLS:C2346820

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UMLS:C2346820

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C2346820

object_name: refractory hematologic cancer


subject: UMLS:C2346820

object_name: Metastatic Breast Carcinoma


subject: UMLS:C2346820

object_name: anemia


subject: UMLS:C2346820

object_name: Anemia, CTCAE


subject: UMLS:C2346820

object_name: myelofibrosis


subject: CHEBI:83766

subject_name: Olaparib

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:83766

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:83766

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:83766

object_name: Blast Phase


subject: CHEBI:83766

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:83766


subject: CHEBI:83766

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:83766

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:83766

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:83766

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:83766

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:83766

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:83766

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:83766

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:83766

object_name: Plasma cell myeloma recurrent


subject: CHEBI:83766

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:83766

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:83766

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:83766

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:83766

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:83766

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:83766

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:83766

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:83766

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:83766

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:83766

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:83766

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:83766

object_name: refractory hematologic cancer


subject: CHEBI:83766

object_name: Plasma cell myeloma refractory


subject: CHEBI:83766

object_name: anemia


subject: CHEBI:83766

object_name: Anemia, CTCAE


subject: CHEBI:83766

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:43805

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:43805

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:43805

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:43805

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:43805

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:43805

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:43805

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:43805

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:43805

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:43805

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:43805

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:43805

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: anemia


subject: PUBCHEM.COMPOUND:43805

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:43805

object_name: myelofibrosis


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C1314429

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UMLS:C1314429

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C1314429

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C1314429

object_name: Blast Phase


subject: UMLS:C1314429

object_name: castration-resistant prostate carcinoma


subject: UMLS:C1314429

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C1314429


subject: UMLS:C1314429

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UMLS:C1314429

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C1314429

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UMLS:C1314429

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1314429

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C1314429

object_name: Recurrent Myeloproliferative Neoplasm


subject: UMLS:C1314429

object_name: Recurrent Hematologic Malignancy


subject: UMLS:C1314429

object_name: Acute lymphoblastic leukemia recurrent


subject: UMLS:C1314429

object_name: Plasma cell myeloma recurrent


subject: UMLS:C1314429

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C1314429

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UMLS:C1314429

object_name: Recurrent Myelodysplastic Syndrome


subject: UMLS:C1314429

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UMLS:C1314429

object_name: B-cell small lymphocytic lymphoma refractory


subject: UMLS:C1314429

object_name: Stage III Non-Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C1314429

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C1314429

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C1314429

object_name: Refractory Primary Myelofibrosis


subject: UMLS:C1314429

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C1314429

object_name: Stage III Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C1314429

object_name: Stage IV Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: refractory hematologic cancer


subject: UMLS:C1314429

object_name: Refractory acute myeloid leukemia


subject: UMLS:C1314429

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C1314429

object_name: Plasma cell myeloma refractory


subject: UMLS:C1314429

object_name: Metastatic Breast Carcinoma


subject: UMLS:C1314429

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C1314429

object_name: anemia


subject: UMLS:C1314429

object_name: Anemia, CTCAE


subject: UMLS:C1314429

object_name: myelofibrosis


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:85993

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:85993

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:85993

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:85993

object_name: Blast Phase


subject: CHEBI:85993

object_name: castration-resistant prostate carcinoma


subject: CHEBI:85993

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:85993


subject: CHEBI:85993

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:85993

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:85993

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:85993

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:85993

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:85993

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:85993

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:85993

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:85993

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:85993

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:85993

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:85993

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:85993

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:85993

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:85993

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:85993

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:85993

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:85993

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:85993

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:85993

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:85993

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:85993

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:85993

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:85993

object_name: refractory hematologic cancer


subject: CHEBI:85993

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:85993

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:85993

object_name: anemia


subject: CHEBI:85993

object_name: Anemia, CTCAE


subject: CHEBI:85993

object_name: myelofibrosis


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:85990

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:85990

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:85990

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:85990

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:85990

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:85990

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:85990

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:85990

object_name: Blast Phase


subject: CHEBI:85990

object_name: castration-resistant prostate carcinoma


subject: CHEBI:85990

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:85990


subject: CHEBI:85990

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:85990

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:85990

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:85990

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:85990

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:85990

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:85990

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:85990

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:85990

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:85990

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:85990

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:85990

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:85990

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:85990

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:85990

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:85990

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:85990

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:85990

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:85990

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:85990

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:85990

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:85990

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:85990

object_name: refractory hematologic cancer


subject: CHEBI:85990

object_name: Refractory acute myeloid leukemia


subject: CHEBI:85990

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:85990

object_name: Metastatic Breast Carcinoma


subject: CHEBI:85990

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:85990

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:85990

object_name: anemia


subject: CHEBI:85990

object_name: Anemia, CTCAE


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:DPT0O3T46P

object_name: leukemia, myeloid, accelerated-phase


subject: UNII:DPT0O3T46P

object_name: Blast Phase


subject: UNII:DPT0O3T46P

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:DPT0O3T46P

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:DPT0O3T46P

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UNII:DPT0O3T46P

object_name: Recurrent Myeloproliferative Neoplasm


subject: UNII:DPT0O3T46P

object_name: Recurrent Hematologic Malignancy


subject: UNII:DPT0O3T46P

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UNII:DPT0O3T46P

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Stage III Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:DPT0O3T46P

object_name: Refractory Primary Myelofibrosis


subject: UNII:DPT0O3T46P

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:DPT0O3T46P

object_name: Stage III Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Stage IV Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: refractory hematologic cancer


subject: UNII:DPT0O3T46P

object_name: anemia


subject: UNII:DPT0O3T46P

object_name: Anemia, CTCAE


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:K16AIQ8CTM

object_name: leukemia, myeloid, accelerated-phase


subject: UNII:K16AIQ8CTM

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:K16AIQ8CTM

object_name: Blast Phase


subject: UNII:K16AIQ8CTM

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:K16AIQ8CTM

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:K16AIQ8CTM

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UNII:K16AIQ8CTM

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:K16AIQ8CTM

object_name: Recurrent Myeloproliferative Neoplasm


subject: UNII:K16AIQ8CTM

object_name: Recurrent Hematologic Malignancy


subject: UNII:K16AIQ8CTM

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:K16AIQ8CTM

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:K16AIQ8CTM

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:K16AIQ8CTM

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UNII:K16AIQ8CTM

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:K16AIQ8CTM

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:K16AIQ8CTM

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:K16AIQ8CTM

object_name: Stage III Non-Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:K16AIQ8CTM

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:K16AIQ8CTM

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:K16AIQ8CTM

object_name: Refractory Primary Myelofibrosis


subject: UNII:K16AIQ8CTM

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:K16AIQ8CTM

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:K16AIQ8CTM

object_name: Stage III Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:K16AIQ8CTM

object_name: Stage IV Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: refractory hematologic cancer


subject: UNII:K16AIQ8CTM

object_name: Refractory acute myeloid leukemia


subject: UNII:K16AIQ8CTM

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:K16AIQ8CTM

object_name: Metastatic Breast Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Refractory Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UNII:K16AIQ8CTM

object_name: anemia


subject: UNII:K16AIQ8CTM

object_name: Anemia, CTCAE


subject: UNII:K16AIQ8CTM

object_name: myelofibrosis


subject: CHEBI:78543

subject_name: Ponatinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:78543

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:78543

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:78543

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:78543

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:78543

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:78543

object_name: castration-resistant prostate carcinoma


subject: CHEBI:78543


subject: CHEBI:78543

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:78543

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:78543

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:78543

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:78543

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:78543

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:78543

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:78543

object_name: Plasma cell myeloma recurrent


subject: CHEBI:78543

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:78543

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:78543

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:78543

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:78543

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:78543

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:78543

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:78543

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:78543

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:78543

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:78543

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:78543

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:78543

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:78543

object_name: refractory hematologic cancer


subject: CHEBI:78543

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:78543

object_name: Plasma cell myeloma refractory


subject: CHEBI:78543

object_name: Metastatic Breast Carcinoma


subject: CHEBI:78543

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:78543

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:78543

object_name: anemia


subject: CHEBI:78543

object_name: Anemia, CTCAE


subject: CHEBI:78543

object_name: myelofibrosis


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:68646

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:68646

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:68646

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:68646

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:68646

object_name: Blast Phase


subject: CHEBI:68646

object_name: castration-resistant prostate carcinoma


subject: CHEBI:68646

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:68646


subject: CHEBI:68646

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:68646

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:68646

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:68646

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:68646

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:68646

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:68646

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:68646

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:68646

object_name: Plasma cell myeloma recurrent


subject: CHEBI:68646

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:68646

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:68646

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:68646

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:68646

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:68646

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:68646

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:68646

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:68646

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:68646

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:68646

object_name: refractory hematologic cancer


subject: CHEBI:68646

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:68646

object_name: Plasma cell myeloma refractory


subject: CHEBI:68646

object_name: Metastatic Breast Carcinoma


subject: CHEBI:68646

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:68646

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:68646

object_name: anemia


subject: CHEBI:68646

object_name: Anemia, CTCAE


subject: CHEBI:68646

object_name: myelofibrosis


subject: CHEBI:68647

subject_name: Regorafenib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:68647

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:68647

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:68647

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:68647

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:68647

object_name: Blast Phase


subject: CHEBI:68647

object_name: castration-resistant prostate carcinoma


subject: CHEBI:68647

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:68647


subject: CHEBI:68647

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:68647

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:68647

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:68647

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:68647

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:68647

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:68647

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:68647

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:68647

object_name: Plasma cell myeloma recurrent


subject: CHEBI:68647

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:68647

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:68647

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:68647

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:68647

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:68647

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:68647

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:68647

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:68647

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:68647

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:68647

object_name: refractory hematologic cancer


subject: CHEBI:68647

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:68647

object_name: Plasma cell myeloma refractory


subject: CHEBI:68647

object_name: Metastatic Breast Carcinoma


subject: CHEBI:68647

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:68647

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:68647

object_name: anemia


subject: CHEBI:68647

object_name: Anemia, CTCAE


subject: CHEBI:68647

object_name: myelofibrosis


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:66919

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:66919

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:66919

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:66919

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:66919

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:66919

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:66919


subject: CHEBI:66919

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:66919

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:66919

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:66919

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:66919

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:66919

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:66919

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:66919

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:66919

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:66919

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:66919

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:66919

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:66919

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:66919

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:66919

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:66919

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:66919

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:66919

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:66919

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:66919

object_name: refractory hematologic cancer


subject: CHEBI:66919

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:66919

object_name: Metastatic Breast Carcinoma


subject: CHEBI:66919

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:66919

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:9168

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:9168

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:9168

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:9168

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:9168

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:9168

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:9168

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:9168

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:9168

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:9168

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:9168

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:9168

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:9168

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:9168

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:9168

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:9168

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:9168

object_name: refractory hematologic cancer


subject: CHEBI:9168

object_name: Refractory acute myeloid leukemia


subject: CHEBI:9168

object_name: Metastatic Breast Carcinoma


subject: CHEBI:9168

object_name: anemia


subject: CHEBI:9168

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:131769963

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:131769963

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:131769963

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:131769963

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:131769963

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:131769963

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Unresectable Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:131769963

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:131769963

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: anemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:131769963

object_name: myelofibrosis


subject: UNII:5XYK65KIGD

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:5XYK65KIGD

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:5XYK65KIGD

object_name: leukemia, myeloid, accelerated-phase


subject: UNII:5XYK65KIGD

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:5XYK65KIGD

object_name: castration-resistant prostate carcinoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:5XYK65KIGD

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:5XYK65KIGD

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:5XYK65KIGD

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:5XYK65KIGD

object_name: Recurrent Myeloproliferative Neoplasm


subject: UNII:5XYK65KIGD

object_name: Recurrent Hematologic Malignancy


subject: UNII:5XYK65KIGD

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:5XYK65KIGD

object_name: Plasma cell myeloma recurrent


subject: UNII:5XYK65KIGD

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UNII:5XYK65KIGD

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:5XYK65KIGD

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:5XYK65KIGD

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:5XYK65KIGD

object_name: Stage III Non-Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Refractory Primary Myelofibrosis


subject: UNII:5XYK65KIGD

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:5XYK65KIGD

object_name: Stage III Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:5XYK65KIGD

object_name: Stage IV Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: refractory hematologic cancer


subject: UNII:5XYK65KIGD

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:5XYK65KIGD

object_name: Metastatic Breast Carcinoma


subject: UNII:5XYK65KIGD

object_name: Refractory Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UNII:5XYK65KIGD

object_name: anemia


subject: UNII:5XYK65KIGD

object_name: Anemia, CTCAE


subject: UNII:5XYK65KIGD

object_name: myelofibrosis


subject: CHEBI:50924

subject_name: Sorafenib

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:50924

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:50924

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:50924

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:50924

object_name: castration-resistant prostate carcinoma


subject: CHEBI:50924

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50924


subject: CHEBI:50924

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:50924

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50924

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:50924

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:50924

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:50924

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:50924

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:50924

object_name: Plasma cell myeloma recurrent


subject: CHEBI:50924

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:50924

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:50924

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:50924

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:50924

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:50924

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:50924

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:50924

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:50924

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:50924

object_name: refractory hematologic cancer


subject: CHEBI:50924

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:50924

object_name: Metastatic Breast Carcinoma


subject: CHEBI:50924

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:50924

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:50924

object_name: anemia


subject: CHEBI:50924

object_name: Anemia, CTCAE


subject: CHEBI:50924

object_name: myelofibrosis


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:38940

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:38940

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:38940

object_name: castration-resistant prostate carcinoma


subject: CHEBI:38940


subject: CHEBI:38940

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:38940

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:38940

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:38940

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:38940

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:38940

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:38940

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:38940

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:38940

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:38940

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:38940

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:38940

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:38940

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:38940

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:38940

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:38940

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:38940

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:38940

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:38940

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:38940

object_name: refractory hematologic cancer


subject: CHEBI:38940

object_name: Refractory acute myeloid leukemia


subject: CHEBI:38940

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:38940

object_name: Metastatic Breast Carcinoma


subject: CHEBI:38940

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:38940

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:38940

object_name: anemia


subject: CHEBI:38940

object_name: Anemia, CTCAE


subject: CHEBI:75998

subject_name: Trametinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:75998

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:75998

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:75998

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:75998

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:75998

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:75998

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:75998

object_name: Blast Phase


subject: CHEBI:75998

object_name: castration-resistant prostate carcinoma


subject: CHEBI:75998

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:75998


subject: CHEBI:75998

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:75998

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:75998

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:75998

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:75998

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:75998

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:75998

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:75998

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:75998

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:75998

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:75998

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:75998

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:75998

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:75998

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:75998

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:75998

object_name: refractory hematologic cancer


subject: CHEBI:75998

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:75998

object_name: Metastatic Breast Carcinoma


subject: CHEBI:75998

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:75998

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:75998

object_name: anemia


subject: CHEBI:75998

object_name: Anemia, CTCAE


subject: CHEBI:75998

object_name: myelofibrosis


subject: UNII:SE2KH7T06F

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:SE2KH7T06F

object_name: leukemia, myeloid, accelerated-phase


subject: UNII:SE2KH7T06F

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:SE2KH7T06F

object_name: Blast Phase


subject: UNII:SE2KH7T06F

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:SE2KH7T06F

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:SE2KH7T06F

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UNII:SE2KH7T06F

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:SE2KH7T06F

object_name: Recurrent Myeloproliferative Neoplasm


subject: UNII:SE2KH7T06F

object_name: Recurrent Hematologic Malignancy


subject: UNII:SE2KH7T06F

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:SE2KH7T06F

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:SE2KH7T06F

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:SE2KH7T06F

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UNII:SE2KH7T06F

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:SE2KH7T06F

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:SE2KH7T06F

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:SE2KH7T06F

object_name: Stage III Non-Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:SE2KH7T06F

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:SE2KH7T06F

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:SE2KH7T06F

object_name: Refractory Primary Myelofibrosis


subject: UNII:SE2KH7T06F

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:SE2KH7T06F

object_name: Stage III Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:SE2KH7T06F

object_name: Stage IV Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: refractory hematologic cancer


subject: UNII:SE2KH7T06F

object_name: Refractory acute myeloid leukemia


subject: UNII:SE2KH7T06F

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:SE2KH7T06F

object_name: Refractory Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UNII:SE2KH7T06F

object_name: anemia


subject: UNII:SE2KH7T06F

object_name: Anemia, CTCAE


subject: UNII:SE2KH7T06F

object_name: myelofibrosis


subject: UMLS:C2826229

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C2826229

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UMLS:C2826229

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C2826229

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C2826229

object_name: Blast Phase


subject: UMLS:C2826229

object_name: castration-resistant prostate carcinoma


subject: UMLS:C2826229

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C2826229


subject: UMLS:C2826229

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UMLS:C2826229

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C2826229

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UMLS:C2826229

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C2826229

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C2826229

object_name: Recurrent Myeloproliferative Neoplasm


subject: UMLS:C2826229

object_name: Recurrent Hematologic Malignancy


subject: UMLS:C2826229

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UMLS:C2826229

object_name: Acute lymphoblastic leukemia recurrent


subject: UMLS:C2826229

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C2826229

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UMLS:C2826229

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UMLS:C2826229

object_name: Recurrent Myelodysplastic Syndrome


subject: UMLS:C2826229

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UMLS:C2826229

object_name: B-cell small lymphocytic lymphoma refractory


subject: UMLS:C2826229

object_name: Stage III Non-Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C2826229

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C2826229

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C2826229

object_name: Refractory Primary Myelofibrosis


subject: UMLS:C2826229

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C2826229

object_name: Stage III Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C2826229

object_name: Stage IV Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: refractory hematologic cancer


subject: UMLS:C2826229

object_name: Refractory acute myeloid leukemia


subject: UMLS:C2826229

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C2826229

object_name: Metastatic Breast Carcinoma


subject: UMLS:C2826229

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C2826229

object_name: anemia


subject: UMLS:C2826229

object_name: Anemia, CTCAE


subject: UMLS:C2826229

object_name: myelofibrosis


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:15367

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:15367

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:15367

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:15367

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:15367

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:15367

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:15367

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:15367

object_name: Blast Phase


subject: CHEBI:15367

object_name: castration-resistant prostate carcinoma


subject: CHEBI:15367

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:15367


subject: CHEBI:15367

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:15367

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:15367

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:15367

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:15367

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:15367

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:15367

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:15367

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:15367

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:15367

object_name: Plasma cell myeloma recurrent


subject: CHEBI:15367

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:15367

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:15367

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:15367

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:15367

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:15367

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:15367

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:15367

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:15367

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:15367

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:15367

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:15367

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:15367

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:15367

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:15367

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:15367

object_name: refractory hematologic cancer


subject: CHEBI:15367

object_name: Refractory acute myeloid leukemia


subject: CHEBI:15367

object_name: Plasma cell myeloma refractory


subject: CHEBI:15367

object_name: Metastatic Breast Carcinoma


subject: CHEBI:15367

object_name: anemia


subject: CHEBI:15367

object_name: Anemia, CTCAE


subject: CHEBI:15367

object_name: myelofibrosis


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:50648

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:50648

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:50648

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:50648

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:50648

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:50648

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:50648

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:50648

object_name: Blast Phase


subject: CHEBI:50648

object_name: castration-resistant prostate carcinoma


subject: CHEBI:50648

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50648


subject: CHEBI:50648

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:50648

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50648

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:50648

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:50648

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:50648

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:50648

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:50648

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:50648

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:50648

object_name: Plasma cell myeloma recurrent


subject: CHEBI:50648

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:50648

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:50648

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:50648

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:50648

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:50648

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:50648

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:50648

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:50648

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:50648

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:50648

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:50648

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:50648

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:50648

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:50648

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:50648

object_name: refractory hematologic cancer


subject: CHEBI:50648

object_name: Refractory acute myeloid leukemia


subject: CHEBI:50648

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:50648

object_name: Plasma cell myeloma refractory


subject: CHEBI:50648

object_name: Metastatic Breast Carcinoma


subject: CHEBI:50648

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:50648

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:50648

object_name: anemia


subject: CHEBI:50648

object_name: Anemia, CTCAE


subject: CHEBI:50648

object_name: myelofibrosis


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:63637

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:63637

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:63637

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:63637

object_name: Blast Phase


subject: CHEBI:63637

object_name: castration-resistant prostate carcinoma


subject: CHEBI:63637

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63637


subject: CHEBI:63637

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:63637

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63637

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:63637

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:63637

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:63637

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:63637

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:63637

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:63637

object_name: Plasma cell myeloma recurrent


subject: CHEBI:63637

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:63637

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:63637

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:63637

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:63637

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:63637

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:63637

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:63637

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:63637

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:63637

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:63637

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:63637

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:63637

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:63637

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:63637

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:63637

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:63637

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:63637

object_name: refractory hematologic cancer


subject: CHEBI:63637

object_name: Refractory acute myeloid leukemia


subject: CHEBI:63637

object_name: Plasma cell myeloma refractory


subject: CHEBI:63637

object_name: Metastatic Breast Carcinoma


subject: CHEBI:63637

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:63637

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:63637

object_name: anemia


subject: CHEBI:63637

object_name: Anemia, CTCAE


subject: CHEBI:63637

object_name: myelofibrosis


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:133021

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:133021

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:133021

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:133021

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:133021

object_name: castration-resistant prostate carcinoma


subject: CHEBI:133021


subject: CHEBI:133021

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:133021

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:133021

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:133021

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:133021

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:133021

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:133021

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:133021

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:133021

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:133021

object_name: refractory hematologic cancer


subject: CHEBI:133021

object_name: Metastatic Breast Carcinoma


subject: CHEBI:133021

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:133021

object_name: anemia


subject: CHEBI:133021

object_name: Anemia, CTCAE


subject: CHEBI:66903

subject_name: Vismodegib

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:66903

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:66903

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:66903

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:66903

object_name: Blast Phase


subject: CHEBI:66903

object_name: castration-resistant prostate carcinoma


subject: CHEBI:66903

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:66903


subject: CHEBI:66903

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:66903

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:66903

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:66903

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:66903

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:66903

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:66903

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:66903

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:66903

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:66903

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:66903

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:66903

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:66903

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:66903

object_name: Unresectable Pancreatic Adenocarcinoma